CLX
Get informed when a big investor buys or sells
+ FollowOctober 30, 2024 - AI Summary
Undervalued by 106.2% based on the discounted cash flow analysis.
| Market cap | $10.45 Billion |
|---|---|
| Enterprise Value | $15.83 Billion |
| Dividend Yield | $4.97 (5.75%) |
| Earnings per Share | $4.82 |
| Beta | 0.58 |
| Outstanding Shares | 121,775,000 |
| P/E Ratio | 17.93 |
|---|---|
| PEG | -35.21 |
| Price to Sales | 1.57 |
| Price to Book Ratio | 43.2 |
| Enterprise Value to Revenue | 2.36 |
| Enterprise Value to EBIT | 16.96 |
| Enterprise Value to Net Income | 26 |
| Total Debt to Enterprise | 0.35 |
| Debt to Equity | 61.33 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 75.77% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 3.78%▼ 82.76% |
|---|---|
| Total Invested | $372.83M▼ 96.29% |
| Investors Holding | 256▼ 848.00% |
No data
The Clorox Company (NYSE: CLX) is a leading multinational manufacturer and marketer of consumer and professional products with about 8,800 employees worldwide and fiscal year 2020 sales of $6.7 billion. Clorox markets some of the most tr...